About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Pancreatic Cancer Risk Warded Off by Common Diabetic Therapy

by Tanya Thomas on August 4, 2009 at 7:59 AM
Font : A-A+

 Pancreatic Cancer Risk Warded Off by Common Diabetic Therapy

A new study has found that a commonly prescribed anti-diabetic drug can reduce an individual's risk of developing pancreatic cancer by 62 percent.

The research from The University of Texas M. D. Anderson Cancer Center has been published in the Aug. 1 issue of Gastroenterology.

Advertisement

"This is the first epidemiological study of metformin in the cancer population, and it offers an exciting direction for future chemoprevention research for a disease greatly in need of both treatment and prevention strategies," said Donghui Li, Ph.D., professor in M. D. Anderson's Department of Gastrointestinal Medical Oncology.

"Metformin works by increasing the cellular sensitivity to insulin and decreasing its level circulating in diabetics. Insulin also seems to have a growth-promoting effect in cancer," said Li, the study's senior author.
Advertisement

"Metformin activates the AMP kinase, which is a cellular engery sensor. Recent publications have described that AMP kinase also plays an important role in the development of cancer by controlling cell division and growth," the expert added.

Li also cited a previous animal study showing that metformin prevented pancreatic tumor development, as well as numerous epidemiologic studies in the diabetic population that showed taking the drug reduced the risk for cancer overall.

"Given these earlier findings, and knowing that diabetes is a risk factor for the development of pancreatic cancer and that 10 percent of such cancers are associated with diabetes, we wanted to better understand the specific association between different anti-diabetic therapies and this lethal disease," explained Li.

For the case control study, the researchers enrolled 1,838 participants - 973 patients with pancreatic adenocarcinoma treated at M. D. Anderson between 2004 and 2008 to compare 863 cancer-free individuals, all companions of M. D. Anderson patients.

Source: ANI
TAN
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Alarming Cesarean Section Trends in India - Convenience or Compulsion of Corporate Healthcare
Quiz on Low-Calorie Diet for Diabetes
World Heart Day in 2022- Use Heart for Every Heart
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Pancreatic Cancer Cancer and Homeopathy Diabetes - Self-Monitoring of Blood Glucose (SMBG) Diabetes and Exercise Reiki and Pranic Healing Cancer Facts Cancer Tattoos A Body Art Pregnancy and Complications Pancreatitis 

Most Popular on Medindia

Pregnancy Confirmation Calculator Find a Hospital Find a Doctor Post-Nasal Drip Hearing Loss Calculator Blood Donation - Recipients Sinopril (2mg) (Lacidipine) Turmeric Powder - Health Benefits, Uses & Side Effects The Essence of Yoga Accident and Trauma Care
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
×

Pancreatic Cancer Risk Warded Off by Common Diabetic Therapy Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests